Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

Brian Orelli’s Featured Articles

CAPS Stats & Trivia

CAPS Player Rating 96.21
Player Rank 2853 out of 75204
Score 1509.86
Score Change Today +0.38
Accuracy 67.14%
Active Picks 73
Total Picks 215
Best Pick MYL (+423.58)
Worst Pick INCY (-1024.97)
Average Score per Pick 7.02
Charms Earned 10
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Three stars, 500 posts CAPS All Star
Board Posts 997
Recs Received 1120
People who have rec'd these posts 443
Recs to Posts Ratio (last 30 days) 6.30
Threads Started 101
Threads Started Percentage 10.13 %
Most Frequent Board Buying or Selling a Home
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 49.25 %
Show TMFBiologyFool’s 10 Latest Posts